论文信息 - Perspectives on the role of Wnt biology in cancer

Perspectives on the role of Wnt biology in cancer

A conference was focused on how to target Wnt signaling pathways for therapeutic benefit. Selected members of the Wnt signaling community met during a 4-day period in October 2018 to discuss the current challenges and opportunities associated with targeting the Wnt pathway for therapeutic benefit. A summary of key points of these discussions is presented in this report.

R. Nusse | D. Tuveson | B. Williams | C. Mirabelli

[1] M. Kagey,et al. Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2] Cassandra R Diegel,et al. Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy , 2018, Bone Research.

[3] M. Kagey,et al. Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology , 2017, British journal of pharmacology.

[4] D. Virshup,et al. First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours. , 2017 .

[5] Joshua S. Kaminker,et al. A resource for cell line authentication, annotation and quality control , 2015, Nature.

[6] T. Holstein,et al. The evolution of the Wnt pathway. , 2012, Cold Spring Harbor perspectives in biology.

[7] E. Vincan,et al. The Wnt signaling pathways and cell adhesion. , 2012, Frontiers in bioscience.